According to the researchers findings, patients in the GLP-1 group had about a 2.56 times higher chance of developing NAION a year later compared to those in the DPP-4 group
: ,
If you plan to resume, restart at the full dose rather than titrating back up, since the break period allows receptor resensitization
IV use at appropriate infusion rates has not shown the same risk profile, but medical history review is standard Individuals with a known sensitivity to sulfur-containing compounds should inform their provider High-dose IV glutathione for cosmetic skin lightening, particularly in unregulated settings, has been associated with adverse events including anaphylaxis and reports of hepatotoxicity
Patients with acromegaly characterized by GH hypersecretion display high IGF-1 levels, and acromegaly patients are highly susceptible to IGF-1 related diseases including diabetes mellitus and BPH, suggesting IGF-1 regulation of various diseases
This helps in maintaining the critical protein sulfhydryl level which is considered necessary for DNA repair and protein function